1. Home
  2. Stocks
  3. Aareydrugs Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Aarey Drugs & Pharmaceuticals Share Price Aarey Drugs & Pharmaceuticals

    Small Cap
    ₹53.25
    +2.5 (4.93%)
    25 April, 2024 12:38 BSE: 524412 NSE: AAREYDRUGSISIN: INE198H01019

    Start SIP in Aarey Drugs & Pharmaceuticals

    Start SIP

    Aarey Drugs & Pharmaceuticals Performance

    Day Range

    • Low 51
    • High 53
    ₹ 53

    52 Week Range

    • Low 27
    • High 68
    ₹ 53
    • Open Price51
    • Previous Close51
    • Volume97008

    Aarey Drugs & Pharmaceuticals Share Price

    • Over 1 Month +12.51%
    • Over 3 Month +0.38%
    • Over 6 Month +20.09%
    • Over 1 Year +93.38%

    Aarey Drugs & Pharmaceuticals Key Statistics

    P/E Ratio 51.6
    PEG Ratio -9.1
    Market Cap Cr 149
    Price to Book Ratio 1.3
    EPS 1.5
    Dividend 0
    Relative Strength Index 63.61
    Money Flow Index 60.98
    MACD Signal 0.49
    Average True Range 2.44
    Aarey Drugs & Pharmaceuticals Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 765851158
    Operating Expenses Qtr Cr 745650160
    Operating Profit Qtr Cr 321-2
    Depreciation Qtr Cr 0000
    Interest Qtr Cr 1111
    Tax Qtr Cr 0002
    Net Profit Qtr Cr 1110
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 422
    Operating Expenses Annual Cr 411
    Operating Profit Annual in Cr 8
    Depreciation Cr 2
    Interest Annual Cr 3
    Tax Annual Cr 2
    Net Profit Annual Cr 4
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr -1
    Cash from Investing Activity Annual Cr 0
    Cash from Financing Annual Activity Cr 1
    Net Cash Flow Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 117
    Fixed Assets Annual Cr 14
    Total Non Current Assets Annual Cr 21
    Total Current Assets Annual Cr 271
    Total Assets Annual Cr 291
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 46
    ROE Annual % 3
    ROCE Annual % 7
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 2
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Aarey Drugs & Pharmaceuticals

    Aarey Drugs & Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹53.25
    +2.5 (4.93%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹47.15
    • 50 Day
    • ₹47.13
    • 100 Day
    • ₹47.31
    • 200 Day
    • ₹45.47
    • 20 Day
    • ₹47.20
    • 50 Day
    • ₹46.23
    • 100 Day
    • ₹48.89
    • 200 Day
    • ₹46.48

    Aarey Drugs & Pharmaceuticals Resistance and Support

    PIVOT
    ₹50.07
    Resistance
    First Resistance 51.43
    Second Resistance 52.12
    Third Resistance 53.48
    RSI 63.61
    MFI 60.98
    MACD Single Line 0.49
    MACD 0.77
    Support
    First Resistance 49.38
    Second Resistance 48.02
    Third Resistance 47.33

    Aarey Drugs & Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 147,531 14,753,100 100
    Week 49,305 4,930,500 100
    1 Month 41,396 4,139,621 100
    6 Month 86,888 6,578,328 75.71

    Aarey Drugs & Pharmaceuticals Result Highlights

    Aarey Drugs & Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    Aarey Drugs & Ph is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company’s Total Operating Revenue is Rs. 418.96 Cr. and Equity Capital is Rs. 25.38 Cr. for the Year ended 31/03/2023. Aarey Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/05/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1990PLC056538 and registration number is 056538.
    Market Cap 146
    Sales 343
    Shares in Float 1.54
    No of funds 2
    Yield 0.44
    Book Value 1.1
    U/D Vol ratio 0.9
    LTDebt / Equity 4
    Alpha 0.16
    Beta 1.07

    Aarey Drugs & Pharmaceuticals

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 45.28%50.04%50.04%50.04%
    Foreign Portfolio Investors 3.4%3.83%3.94%3.92%
    Individual Investors 47.14%41.14%40.61%42.14%
    Others 4.18%4.99%5.41%3.9%

    Aarey Drugs & Pharmaceuticals Management

    Name Designation
    Mr. Mihir R Ghatalia Chairman & Managing Director
    Mr. Nimit Rajesh Ghatalia Executive Director
    Ms. Archana Pramod Wani Woman Director
    Mr. Lalit Radhakrishna Tulsiani Independent Director
    Mr. Anil Mandal Independent Director
    Mr. Chetan K Mehta Independent Director

    Aarey Drugs & Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Aarey Drugs & Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-03-27 Others Inter alia, to consider the allotment of Equity Shares and Warrants.
    2024-02-14 Quarterly Results
    2023-11-11 Quarterly Results
    2023-08-14 Quarterly Results
    2023-08-10 Preferential issue & Issue of Warrants

    Aarey Drugs & Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Aarey Drugs & Pharmaceuticals FAQs

    What is Share Price of Aarey Drugs & Pharmaceuticals ?

    Aarey Drugs & Pharmaceuticals share price is ₹53 As on 25 April, 2024 | 12:24

    What is the Market Cap of Aarey Drugs & Pharmaceuticals ?

    The Market Cap of Aarey Drugs & Pharmaceuticals is ₹149.4 Cr As on 25 April, 2024 | 12:24

    What is the P/E ratio of Aarey Drugs & Pharmaceuticals ?

    The P/E ratio of Aarey Drugs & Pharmaceuticals is 51.6 As on 25 April, 2024 | 12:24

    What is the PB ratio of Aarey Drugs & Pharmaceuticals ?

    The PB ratio of Aarey Drugs & Pharmaceuticals is 1.3 As on 25 April, 2024 | 12:24

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.